TrialPanorama/TrialPanorama-database huggingface dataset:
Primary endpoint: Efedrine Consumption
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Atropine Consumption
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Change in Family Supportive Supervisor Behaviors
Endpoint domain: Life impact
Endpoint subdomain: Social functioning
Primary endpoint: Change in Leave Supportive Supervisor Behaviors
Endpoint domain: Life impact
Endpoint subdomain: Social functioning
Primary endpoint: Improved Acute Physiology and Chronic Health Evaluation score II score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: cure d14
Endpoint domain: Mortality/survival
Primary endpoint: cure d7
Endpoint domain: Mortality/survival
Primary endpoint: Rate of healthcare utilization
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Severe late toxicity grade 3
Endpoint domain: Adverse events/effects
Primary endpoint: Change in A1C at Week 22
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Change in Diabetes Self-management Adherence at Week 22
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Change in Glucose Variability at Week 22
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Change From Baseline to Week 22 in the Number of Correct Responses in 90 Seconds on the Symbol Digit Modalities Test
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cognitive functioning
Primary endpoint: Total weight of household food waste
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Presence of symptoms at the vulvovaginal level and their intensity
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Impact in the quality of life of vulvo-vaginal symptoms
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Changes in vulvar physical examination
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Stroke Work
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Potential Energy
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Pressure-Volume Area
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Intrarenal venous flow patterns
Endpoint domain: Physiological/clinical
Endpoint subdomain: Renal and urinary outcomes
Primary endpoint: KOOS-Child Pain subscale
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: 30-meter sprint
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: 15-repeated-jumps test
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Time to improvement of at least 2 categories on WHO 8-point ordinal scale
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Hypertonic metrics of the pelvic muscles
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: number of patients with fluid overload
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Attention - Digit Span Forward Task
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cognitive functioning
Primary endpoint: Level of inflammation
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Frequency of anastomotic leakage
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: Rate of survival with renal recovery
Endpoint domain: Mortality/survival
Primary endpoint: nausea and vomiting score
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: Intervention effectiveness
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Rate of hypoxemic respiratory failure at day 7
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Rate of hypoxemic respiratory failure at day 28
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: BOLD-level activity
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in fatigue intensity (MFI-20 score)
Endpoint domain: Life impact
Endpoint subdomain: Fatigue
Primary endpoint: Walking distance (6 Minute Walking Test score)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Femoral component osseous-integration
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in TUG cognitive test score
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: Frequency of thoughts about idiosyncratic stressor
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: Impact of thoughts about idiosyncratic stressor
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Maximum tolerated dose (MTD) or maximum administrated dose (MAD)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Assessment of repigmentation
Endpoint domain: Physiological/clinical
Endpoint subdomain: Skin and subcutaneous tissue outcomes
Primary endpoint: Lactose intolerance symptoms
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Low Back Pain and Disability
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Sensitivity and specificity of the EarlyTect® CRC test
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Measurement of fiducial marker or transponder motion
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Precision of the AI algorithm
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Frequency of therapeutic adjustments
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Change in Depression, Anxiety and Stress Scale - 21 (DASS-21)
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Change in World Health Organization Quality of Life (WHOQoL-BREF) scale
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Change of wound bed condition
Endpoint domain: Physiological/clinical
Endpoint subdomain: Skin and subcutaneous tissue outcomes
Primary endpoint: Incidence of grade 3 and/or 4 adverse events of special interest
Endpoint domain: Adverse events/effects
Primary endpoint: Incidence of any adverse events requiring hospitalization
Endpoint domain: Adverse events/effects
Primary endpoint: Percentage of participants achieving HBsAg seroclearance
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Percentage of participants with treatment-emergent adverse events (TEAEs) and serious adverse events (SAEs)
Endpoint domain: Adverse events/effects
Primary endpoint: Proportion of accurate gastric tube placement
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Number of ITP patients who receive Fostamatinib
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Change in CAPS score from pre-treatment to post-treatment
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in CAPS score from post-treatment to 3-month follow-up
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: AUC of total radioactivity, parent drug and metabolite(s) in plasma
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Cmax of total reactivity, parent drug and metabolite(s) in plasma
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Tmax of total reactivity, parent drug and metabolite(s) in plasma
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Efficacy of laparoscopic versus open appendectomy
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Safety of laparoscopic versus open appendectomy
Endpoint domain: Adverse events/effects
Primary endpoint: Intake of energy and nutrients
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Intake of ultraprocessed foods
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Adherence to the Mediterranean Diet
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Quality of life of IHD patients
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Suppression of Endogenous glucose production (EGP) by insulin
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Insulin pulse orderliness
Endpoint domain: Physiological/clinical
Endpoint subdomain: Endocrine outcomes
Primary endpoint: Number of in-hospital mortalities
Endpoint domain: Mortality/survival
Primary endpoint: Tear Film Break Up Time (TFBUT)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Suprasternal Adipose Tissue Thickness
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: toxoplasma IgG levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Spatiotemporal Parameters
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in Visual acuity
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Biochemical Assessment
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Cumulative probability of sputum culture conversion
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Cumulative probability of permanent discontinuation of at least one anti-TB drug due to adverse events, intolerance, or death
Endpoint domain: Adverse events/effects
Primary endpoint: Maximum Observed Plasma Concentration (Cmax) of JNJ-64281802
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Apparent Terminal Elimination Half-life (t1/2) of JNJ-64281802
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Area Under the Curve From Time Zero to Last Measurable Concentration (AUC[0-last]) of JNJ-64281802
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Quality-of-life by EQ-5D scale
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: TSLP expression in nasal epithelium
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Area under the plasma concentration time curve from zero to the last quantifiable concentration (AUClast)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Quality of life in patients with MS
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Glucose (OGTT)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Insulin (OGTT)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Monocyte/macrophage populations by flow cytometry
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Percentage of eligible patients prescribed MRA
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Incidence of postoperative neurocognitive disorder
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: modified ranking scale on day 90
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Child-Parent Relationship
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Coparenting Relationship
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Change in acceptability for the PRISEM pilot
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Seizure improvement
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: HIV pre-exposure prophylaxis (PrEP) initiation
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Time to recovery to a normal platelet level
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: Dentinal hypersensitivity measured by VAS
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Dentinal hypersensitivity measured by Schiff scale
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Percent change in TDC level from baseline
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Percent change in tissue oxygenation saturation level from baseline
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Percent change in tissue temperature gradient from baseline
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: cfDNA methylation markers
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Number of participants experiencing Cytokine Release Syndrome (CRS)
Endpoint domain: Adverse events/effects
Primary endpoint: Number of participants experiencing Immune Effector Cell Neurotoxicity (ICANS)
Endpoint domain: Adverse events/effects
Primary endpoint: Usability of the JomPrEP app
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Acceptability of the JomPrEP app
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Maximum Concentration (Cmax) of Solriamfetol in Breast Milk and Plasma
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Time to Reach Maximum Concentration (Cmax) (Tmax) in Breast Milk and Plasma
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Area Under the Concentration-Time Curve From Time 0 to Infinity (AUC 0-inf) in Breast Milk and Plasma
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Positive predictive value on a lesion level
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Severity of menopausal syndrome
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: VAS Scala
Endpoint domain: Life impact
Endpoint subdomain: Pain
Primary endpoint: Comprehensive Complication Index score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Reduction of inflammatory burden
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Tau synthesis rate inhibition
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Within-test agreement of wheal positivity
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Immunomodulatory capacity
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Frequency of sleep bruxism
Endpoint domain: Life impact
Endpoint subdomain: Sleep
Primary endpoint: Use of Magtrace® as a tracer in SLN sampling
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Cmax of Tacrolimus
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Tmax of Tacrolimus
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: AUClast of Tacrolimus
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Characteristic features of leukoderma disorders
Endpoint domain: Physiological/clinical
Endpoint subdomain: Skin and subcutaneous tissue outcomes
Primary endpoint: Time to achievement of therapeutic endpoints of hemodynamics
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: All solicited and unsolicited adverse events
Endpoint domain: Adverse events/effects
Primary endpoint: changes in the number of comedones, papules, and pustules
Endpoint domain: Physiological/clinical
Endpoint subdomain: Skin and subcutaneous tissue outcomes
Primary endpoint: Muscle mass and Weight
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Appropriate GWG ratios with IOM guideline
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Healthy living behavior scale score
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Radiation Fibrosis
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: interference rate
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: brain connectivity change
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Area under the plasma concentration-versus-time curve (AUC0-last and AUC0-∞)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: student stress level
Endpoint domain: Life impact
Endpoint subdomain: Fatigue
Primary endpoint: students anxiety
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: MOXFQ
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: vaccination status among minors 12-17 years
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Annual Rate of the Physiologically Adjusted Lung Density Change
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Prevalence of mast cell activation syndrome
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Stair Climbing Test (SCT)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Overall R0/R1 resection rate
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Insufficient Milk Perception Scale
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Undetectable prostate specific antigen (PSA)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: Accuracy of pulp exposure prediction
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Sensitivity of pulp exposure prediction
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Specificity of pulp exposure prediction
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in FVIII activity
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Assessment of ANB-010 safety
Endpoint domain: Adverse events/effects
Primary endpoint: FBUT
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Changes in perioperative core body temperature
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: optic nerve sheath diameter [ONSD]
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: carbon dioxide partial pressure
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: mean airway pressure (PAWM)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: peak airway pressure (PAP)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: esophageal pressure (PES)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: tidal volume (TV)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Efficacy in functionality
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Recovery in time
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Functionality facial
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Occurrence of acute respiratory infection leading to hospitalization
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Proportion of subjects with Grade 0, 1 or 2 functional disability (PCFS)
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Proportion of subjects with Grade 0, 1 or 2 functional disability (FSS)
Endpoint domain: Life impact
Endpoint subdomain: Fatigue
Primary endpoint: blood loss in the operative theatre
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: change of immune-related adverse events
Endpoint domain: Adverse events/effects
Primary endpoint: Incidence of enteral feed interruptions
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Diagnostic rate of ultrasound with IV contrast
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Safety of Radical Nephrectomy
Endpoint domain: Adverse events/effects
Primary endpoint: Feasibility of Radical Nephrectomy
Endpoint domain: Physiological/clinical
Endpoint subdomain: Renal and urinary outcomes
Primary endpoint: AUC of the NRS-A for pain
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Percentage of endoFAVI physiologically appropriate for hemodialysis
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Absence of oral/GI severe regimen related toxicities
Endpoint domain: Adverse events/effects
Primary endpoint: Acute exacerbation rate
Endpoint domain: Adverse events/effects
Primary endpoint: State anxiety and trait anxiety
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Experimental Heat Pain Thresholds
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Experimental Pressure Pain Thresholds
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Experimental Pain Sensitivity
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: number of postoperative pancreatic fistula
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes